Insulet Corp. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares rose 2.02% to $167.37, outperforming competitors like Eli Lilly, DexCom, and Johnson & Johnson during a broader market decline on July 20, 2026. Trading volume of 1.7 million exceeded the 50-day average. Despite this daily gain, Insulet's stock remains 52.84% below its 52-week high of $354.88 reached in November.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) advanced 2.02% to $167.37 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
Insulet Corp. closed 52.84% below its 52-week high of $354.88, which the company reached on November 20th.
The stock outperformed some of its competitors Monday, as Eli Lilly & Co. (LLY) fell 2.73% to $1,146.90, DexCom Inc. (DXCM) fell 1.25% to $75.69, and Johnson & Johnson (JNJ) fell 1.67% to $248.82.
Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1716ET